Radiation Toxicity Treatment Market - Global Industry Analysis and Opportunity Assessment, 2019-2029

Radiation Toxicity Treatment Market - Global Industry Analysis and Opportunity Assessment, 2019-2029

A recent market study published by Future Market Insights on the radiation toxicity treatment market includes global industry analysis for 2014 - 2018 & opportunity assessment for 2019 - 2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the radiation toxicity treatment market, the growth prospects of the market are obtained with maximum precision.

Chapter 01 – Executive Summary
The report initiates with the executive summary of the radiation toxicity treatment market, which includes a summary of key findings and statistics of the market. It also includes supply-side and demand-side trends pertaining to the radiation toxicity treatment market.

Chapter 02 – Market Overview
Readers can find the definition and a detailed segmentation of the radiation toxicity treatment market in this chapter, which will help them understand the basic information about the radiation toxicity treatment market. Along with this, comprehensive information pertaining to radiation toxicity treatment and their properties are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the radiation toxicity treatment market report.

Chapter 03 – Market Dynamics
This section gives information about drivers, and restraints of the radiation toxicity treatment market. This section also includes various opportunities of the radiation toxicity treatment market.

Chapter 04 – Market Context
This section gives information about upcoming pipeline products, therapeutic efficacy and treatment metrics, and regulatory scenario of the radiation toxicity treatment market.

Chapter 05 – Global Radiation Toxicity Treatment Market Demand Analysis 2014-2018 & Opportunity Assessment 2019-2029
This section explains the global market value analysis and forecast for the radiation toxicity treatment market between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical radiation toxicity treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Product
Based on product type, the radiation toxicity treatment market is segmented into colony stimulating factors, potassium iodide, prussian blue, diethylenetriamine pentaacetic acid, others. In this chapter, readers can find information about the Y-o-Y growth and market attractiveness analysis based on product type.

Chapter 07 – Global Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Indication
Based on indication, the radiation toxicity treatment market is segmented into acute radiation syndrome and chronic radiation syndrome. In this chapter, readers can understand the Y-o-Y growth and market attractiveness analysis based on application.

Chapter 08 – Global Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Radiation
Based on radiation type, the radiation toxicity treatment market is segmented into ionizing radiation and non-ionizing radiation. In this chapter, readers can understand the Y-o-Y growth and market attractiveness analysis based on radiation type.

Chapter 09 – Global Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by End User
This chapter provides details about the radiation toxicity treatment market based on the end user, and has been classified into hospitals and research & academic institutes. In this chapter, readers can understand the market attractiveness analysis based on end user.

Chapter 10 – Global Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region
This chapter explains how the radiation toxicity treatment market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa (MEA).

Chapter 11 – North America Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter includes a detailed analysis of the growth of the North America radiation toxicity treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the product type, indication, radiation type, end user, and countries in North America.

Chapter 12 – Latin America Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter provides the growth scenario of the radiation toxicity treatment market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 13 – Europe Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029
Important growth prospects of the radiation toxicity treatment market based on its end users in several countries such as the U.K., France, Germany, Spain, Italy, and the Rest of Europe are included in this chapter.

Chapter 14 – East Asia Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029
Important growth prospects of the radiation toxicity treatment market across target segments in several countries such as China, Japan and South Korea are included in this chapter.

Chapter 15 – South Asia Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029
In this chapter, India, Indonesia, Thailand, Malaysia countries are the prominent countries in the South Asia region. Readers can find detailed information about the growth parameters of the South Asia radiation toxicity treatment market during the forecast period of 2019-2029.

Chapter 16 – Oceania Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029
This section highlights the growth prospects of the radiation toxicity treatment market for Australia and New Zealand, during the forecast period of 2019-2029.

Chapter 17 – MEA Radiation Toxicity Treatment Market Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter provides information about how the radiation toxicity treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 18 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in radiation toxicity treatment market.

Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the radiation toxicity treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Amgen Inc., Partner Therapeutics, Inc., Novartis AG, Mylan NV, Coherus BioSciences Inc., Jubilant Life Sciences, Hameln Pharma Plus Gmbh, Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, Recipharm AB, Annex Inc., Mission Pharmacal Company, Avondale Pharmaceuticals, Llc. and Upsher-Smith Laboratories, LLC.

Chapter 20 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the radiation toxicity treatment market report.

Chapter 21 – Research Methodology
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the radiation toxicity treatment market.


1. Executive Summary
1.1. Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Macro-Economic Factors
3.2. Forecast Factors - Relevance & Impact
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunity
4. Key Success Factors
4.1. FDA Approved Drugs
4.2. Pipeline Assessment
4.3. Therapeutic Efficacy and Treatment Metrics
4.4. Predisposing Factors
5. Radiation Toxicity Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Product Type
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019-2029
6.3.1. Colony Stimulating Factors
6.3.2. Prussian blue
6.3.3. Diethylenetriamine Pentaacetic Acid
6.3.4. Potassium iodide
6.3.5. Others
6.4. Market Attractiveness Analysis By Product Type
7. Global Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Indication
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019-2029
7.3.1. Acute Radiation Syndrome (ARS)
7.3.1.1. Bone Marrow Syndrome (Hematopoietic)
7.3.1.2. Gastrointestinal Syndrome (GI)
7.3.1.3. Cardiovascular (CV)
7.3.1.4. Central Nervous System (CNS) Syndrome
7.3.2. Chronic Radiation Syndrome
7.4. Market Attractiveness Analysis By Indication
8. Global Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Radiation Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Radiation Type, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Radiation Type, 2019-2029
8.3.1. Ionizing Radiation
8.3.1.1. Alpha Radiation
8.3.1.2. Beta Radiation
8.3.1.3. Gama Radiation
8.3.2. Non-Ionizing radiation
8.4. Market Attractiveness Analysis By Radiation Type
9. Global Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2014-2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019-2029
9.3.1. Hospitals
9.3.1.1. Government Hospitals
9.3.1.2. Private Hospitals
9.3.2. Research & Academic Institutes
9.3.2.1. Government research and academic institutes
9.3.2.2. Private research and academic institutes
9.4. Market Attractiveness Analysis By End User
10. Global Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2029
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East & Africa
10.4. Market Attractiveness Analysis By Region
11. North America Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Product Type
11.3.3. By Radiation Type
11.3.4. By Indication
11.3.5. By End User
11.4. Market Attractiveness Analysis
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis
12. Latin America Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product Type
12.3.3. By Radiation Type
12.3.4. By Indication
12.3.5. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Europe Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. Rest of Europe
13.3.2. By Product Type
13.3.3. By Radiation Type
13.3.4. By Indication
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. East Asia Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Product Type
14.3.3. By Radiation Type
14.3.4. By Indication
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. South Asia Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product Type
15.3.3. By Radiation Type
15.3.4. By Indication
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Oceania Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product Type
16.3.3. By Radiation Type
16.3.4. By Indication
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Middle East & Africa Radiation Toxicity Treatment Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. South Africa
17.3.1.4. Rest of MEA
17.3.2. By Product Type
17.3.3. By Radiation Type
17.3.4. By Indication
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Market Structure Analysis
18.1. Tier Structure Analysis
18.2. Market Concentration
18.3. Company Share Analysis
18.4. Company Footprint Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Deep Dive
19.2.1. Amgen Inc.
19.2.1.1. Overview
19.2.1.2. Product Portfolio
19.2.1.3. Profitability by Market Segments (Product/Region)
19.2.1.4. Sales Footprint
19.2.1.5. Strategy Overview
19.2.1.5.1. Marketing Strategy
19.2.1.5.2. Product Strategy
19.2.2. Partner Therapeutics, Inc.
19.2.2.1. Overview
19.2.2.2. Product Portfolio
19.2.2.3. Profitability by Market Segments (Product/Region)
19.2.2.4. Sales Footprint
19.2.2.5. Strategy Overview
19.2.2.5.1. Marketing Strategy
19.2.2.5.2. Product Strategy
19.2.3. Novartis AG
19.2.3.1. Overview
19.2.3.2. Product Portfolio
19.2.3.3. Profitability by Market Segments (Product/Region)
19.2.3.4. Sales Footprint
19.2.3.5. Strategy Overview
19.2.3.5.1. Marketing Strategy
19.2.3.5.2. Product Strategy
19.2.4. Mylan NV
19.2.4.1. Overview
19.2.4.2. Product Portfolio
19.2.4.3. Profitability by Market Segments (Product/Region)
19.2.4.4. Sales Footprint
19.2.4.5. Strategy Overview
19.2.4.5.1. Marketing Strategy
19.2.4.5.2. Product Strategy
19.2.5. Coherus BioSciences Inc
19.2.5.1. Overview
19.2.5.2. Product Portfolio
19.2.5.3. Profitability by Market Segments (Product/Region)
19.2.5.4. Sales Footprint
19.2.5.5. Strategy Overview
19.2.5.5.1. Marketing Strategy
19.2.5.5.2. Product Strategy
19.2.6. Jubilant Life Sciences
19.2.6.1. Overview
19.2.6.2. Product Portfolio
19.2.6.3. Profitability by Market Segments (Product/Region)
19.2.6.4. Sales Footprint
19.2.6.5. Strategy Overview
19.2.6.5.1. Marketing Strategy
19.2.6.5.2. Product Strategy
19.2.7. Siegfried Holdings
19.2.7.1. Overview
19.2.7.2. Product Portfolio
19.2.7.3. Profitability by Market Segments (Product/Region)
19.2.7.4. Sales Footprint
19.2.7.5. Strategy Overview
19.2.7.5.1. Marketing Strategy
19.2.7.5.2. Product Strategy
19.2.8. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
19.2.8.1. Overview
19.2.8.2. Product Portfolio
19.2.8.3. Profitability by Market Segments (Product/Region)
19.2.8.4. Sales Footprint
19.2.8.5. Strategy Overview
19.2.8.5.1. Marketing Strategy
19.2.8.5.2. Product Strategy
19.2.9. Recipharm AB
19.2.9.1. Overview
19.2.9.2. Product Portfolio
19.2.9.3. Profitability by Market Segments (Product/Region)
19.2.9.4. Sales Footprint
19.2.9.5. Strategy Overview
19.2.9.5.1. Marketing Strategy
19.2.9.5.2. Product Strategy
19.2.10. Mission Pharmacal Company
19.2.10.1. Overview
19.2.10.2. Product Portfolio
19.2.10.3. Profitability by Market Segments (Product/Region)
19.2.10.4. Sales Footprint
19.2.10.5. Strategy Overview
19.2.10.5.1. Marketing Strategy
19.2.10.5.2. Product Strategy
20. Assumptions and Acronyms Used
21. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings